These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22488901)

  • 1. Nanoformulations for molecular MRI.
    Tu C; Louie AY
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):448-57. PubMed ID: 22488901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 3. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.
    Zeinali Sehrig F; Majidi S; Asvadi S; Hsanzadeh A; Rasta SH; Emamverdy M; Akbarzadeh J; Jahangiri S; Farahkhiz S; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1583-8. PubMed ID: 26584684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
    Medarova Z; Balcioglu M; Yigit MV
    Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent.
    Zhao X; Zhao H; Chen Z; Lan M
    J Nanosci Nanotechnol; 2014 Jan; 14(1):210-20. PubMed ID: 24730260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging?
    Ploussi AG; Gazouli M; Stathis G; Kelekis NL; Efstathopoulos EP
    Cardiol Rev; 2015; 23(5):229-35. PubMed ID: 25688663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave-Driven Synthesis of Iron-Oxide Nanoparticles for Molecular Imaging.
    Fernández-Barahona I; Muñoz-Hernando M; Herranz F
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting an old friend: manganese-based MRI contrast agents.
    Pan D; Caruthers SD; Senpan A; Schmieder AH; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):162-73. PubMed ID: 20860051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of tumour targeted T1 based MRI contrast agents.
    Kamaly N; Miller AD; Bell JD
    Curr Top Med Chem; 2010; 10(12):1158-83. PubMed ID: 20388110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T
    Zhou H; Qiu X; Shen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):427-444. PubMed ID: 32376585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications.
    Vojtech JM; Cano-Mejia J; Dumont MF; Sze RW; Fernandes R
    J Vis Exp; 2015 Apr; (98):e52621. PubMed ID: 25993028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
    Shen Z; Wu A; Chen X
    Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.
    Misri R; Meier D; Yung AC; Kozlowski P; Häfeli UO
    Nanomedicine; 2012 Aug; 8(6):1007-16. PubMed ID: 22100757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimodal magnetic-fluorescent probes for bioimaging.
    Jańczewski D; Zhang Y; Das GK; Yi DK; Padmanabhan P; Bhakoo KK; Tan TT; Selvan ST
    Microsc Res Tech; 2011 Jul; 74(7):563-76. PubMed ID: 20734412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.